Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease.

Sato T, Fujii T, Yokoyama T, Fujita Y, Imura Y, Yukawa N, Kawabata D, Nojima T, Ohmura K, Usui T, Mimori T.

Arthritis Rheum. 2010 Dec;62(12):3730-40. doi: 10.1002/art.27700.

2.

Serum antibodies against the 70k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus: a retrospective study.

Katsumata Y, Kawaguchi Y, Baba S, Hattori S, Tahara K, Ito K, Iwasaki T, Yamaguchi N, Hattori H, Nagata K, Okamoto Y, Yamanaka H, Hara M.

Mod Rheumatol. 2013 Jan;23(1):71-80. doi: 10.1007/s10165-012-0624-y. Epub 2012 Mar 28.

PMID:
22454191
3.

Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.

Yoshio T, Hirata D, Onda K, Nara H, Minota S.

J Rheumatol. 2005 Jan;32(1):34-9.

PMID:
15630721
4.

Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.

Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Catani C, Fagiolo U, Gambari PF.

Rheumatol Int. 1996;16(4):145-50.

PMID:
8961378
5.

Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.

Hirohata S, Sakuma Y, Yanagida T, Yoshio T.

Arthritis Res Ther. 2014 Oct 2;16(5):450. doi: 10.1186/s13075-014-0450-z.

6.

A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.

Greidinger EL, Zang Y, Jaimes K, Hogenmiller S, Nassiri M, Bejarano P, Barber GN, Hoffman RW.

Arthritis Rheum. 2006 Feb;54(2):661-9.

7.

[Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].

Miyamae T, Ito S, Machida H, Ozawa R, Higuchi R, Nakajima S, Imagawa T, Nakamura T, Mori M, Aihara Y, Ohshige K, Yokota S.

Nihon Rinsho Meneki Gakkai Kaishi. 2008 Oct;31(5):405-14. Japanese.

8.

The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.

Jönsen A, Bengtsson AA, Nived O, Ryberg B, Truedsson L, Rönnblom L, Alm GV, Sturfelt G.

Lupus. 2003;12(11):846-50.

PMID:
14667101
9.

Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.

George-Chandy A, Trysberg E, Eriksson K.

Arthritis Res Ther. 2008;10(4):R97. doi: 10.1186/ar2484. Epub 2008 Aug 22.

10.

Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.

Ikeda K, Takasaki Y, Hirokawa K, Takeuchi K, Hashimoto H.

J Rheumatol. 2003 May;30(5):998-1005.

PMID:
12734895
11.

Increase of cytokine production by pulmonary artery endothelial cells induced by supernatants from monocytes stimulated with autoantibodies against U1-ribonucleoprotein.

Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Kinoshita M, Sumiya M.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6):705-12.

PMID:
10609069
12.

Clinical significance of U1-RNP immune complexes in mixed connective tissue disease and systemic lupus erythematosus.

Negoro N, Kanayama Y, Takeda T, Amatsu K, Koda S, Inoue Y, Kim T, Okamura M, Inoue T.

Rheumatol Int. 1987;7(1):7-11.

PMID:
2954202
13.

Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus.

Yokoyama T, Fujii T, Kondo-Ishikawa S, Yamakawa N, Nakano M, Yukawa N, Yoshifuji H, Ohmura K, Mimori T.

Lupus. 2014 Jun;23(7):635-42. doi: 10.1177/0961203314522337. Epub 2014 Feb 3.

PMID:
24493282
14.

Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.

Arinuma Y, Yanagida T, Hirohata S.

Arthritis Rheum. 2008 Apr;58(4):1130-5. doi: 10.1002/art.23399.

15.

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J.

PLoS One. 2008 Oct 6;3(10):e3347. doi: 10.1371/journal.pone.0003347.

16.

Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.

Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.

Arthritis Rheum. 2005 Jun;52(6):1670-5.

17.

Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.

Margaux J, Hayem G, Palazzo E, Chazerain P, De Bandt M, Haim T, Kahn MF, Meyer O.

Rev Rhum Engl Ed. 1998 Jun;65(6):378-86.

PMID:
9670329
18.

Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.

Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.

Arthritis Rheum. 2009 Jul;60(7):2094-101. doi: 10.1002/art.24603.

19.

Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus.

Vlachoyiannopoulos PG, Guialis A, Tzioufas G, Moutsopoulos HM.

Br J Rheumatol. 1996 Jun;35(6):534-41.

20.

Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.

Komatireddy GR, Wang GS, Sharp GC, Hoffman RW.

J Rheumatol. 1997 Feb;24(2):319-22.

PMID:
9034990
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk